Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human papillomavirus (HPV) capsid is primarily composed of two structural proteins: the major capsid protein L1 and the minor capsid protein L2. L1 self-assembles into pentamers forming the icosahedral capsid protecting the viral DNA. Recombinant L1 forms virus-like particles (VLPs), the basis of prophylactic HPV vaccines. L2 assists genome encapsulation and intracellular trafficking. The capsid is essential for infection and a key target for preventative vaccines.
HPV vaccines induce neutralizing antibodies against L1 protein, preventing viral entry and infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Capsid Protein (HPV Capsid Protein).